Brooks Laboratories rises on incorporating wholly owned subsidiary
Brooks Laboratories is currently trading at Rs. 76.50, up by 0.50 points or 0.66% from its previous closing of Rs. 76.00 on the BSE.
The scrip opened at Rs. 76.00 and has touched a high and low of Rs. 79.00 and Rs. 76.00 respectively. So far 5061 shares were traded on the counter.
The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 165.95 on 14-Aug-2025 and a 52 week low of Rs. 36.90 on 30-Mar-2026.
Last one week high and low of the scrip stood at Rs. 79.00 and Rs. 67.20 respectively. The current market cap of the company is Rs. 225.35 crore.
The promoters holding in the company stood at 52.62%, while Institutions and Non-Institutions held 10.07% and 37.32% respectively.
Brooks Laboratories has incorporated a wholly owned subsidiary (WOS) in the name of Abridge Speciality on July 2, 2026. The Certificate of Incorporation has been issued by the Ministry of Corporate Affairs on the same day. The incorporation of WOS aligns with the company's strategic objective to expand its business.
